A pre-clinical study to investigate the anti-diabetic potential of p-propoxybenzoic acid as a multi-target inhibitor in streptozotocin-nicotinamide induced type-2 diabetic rats-Reference-Cited by-同舟云学术

A pre-clinical study to investigate the anti-diabetic potential of p-propoxybenzoic acid as a multi-target inhibitor in streptozotocin-nicotinamide induced type-2 diabetic rats

Published:2022-12-31 Issue: Volume: Page:
ISSN:2251-6581
Container-title:Journal of Diabetes & Metabolic Disorders
language:en
Short-container-title:J Diabetes Metab Disord

Author:

Raval Keval Y.^ORCID,Tirgar Pravin R.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40200-022-01177-y.pdf

Reference42 articles.

1. Khan MA, Hashim MJ, King JK, Govender RD, Mustafa H, Al KJ. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. J Epidemiol Glob Health. 2019;10(1):107.

2. Teimouri M, Hosseini H, ArabSadeghabadi Z, Babaei-Khorzoughi R, Gorgani-Firuzjaee S, Meshkani R. The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications. J Physiol Biochem. 2022;78(2):307–22.

3. Kaur N, Kumar V, Nayak SK, Wadhwa P, Kaur P, Sahu SK. Alpha-amylase as molecular target for treatment of diabetes mellitus: A comprehensive review. Chem Biol Drug Des. 2021;98(4):539–60.

4. YenFS, Wei JCC, Lin MC, Hu CC, Hwu CM. Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes. BMC Endocr Disord. 2021;21(1):1–0. https://doi.org/10.1186/s12902-021-00690-0

5. Frkic RL, Richter K, Bruning JB. The therapeutic potential of inhibiting PPARΓ phosphorylation to treat type 2 diabetes. J Biol Chem. 2021;297(3):101030.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An in-silico and in-vitro approach for the exploration of preliminary anti-cancer potential of p-propoxybenzoic acid through inhibition of protein tyrosine phosphatase 1B enzyme;Proceedings of the Indian National Science Academy;2024-09-12

2. Development of an Experimental Animal Screening Model for Induction of type-3 Diabetes Mellitus using High-fat Diet, Streptozotocin, and Nicotinamide;Medical Journal of Dr. D.Y. Patil Vidyapeeth;2024-06-17

3. In-vivo Screening for the Antiasthmatic Potential of Salicin through the Murine Models of Asthma and Airway Remodeling;Medical Journal of Dr. D.Y. Patil Vidyapeeth;2024-06-17

4. Emerging paradigms in pre-clinical screening models for drugs acting against diabetes: Delving into complex approaches and advancements;International Journal of Pharmaceutical Chemistry and Analysis;2023-07-15

5. An extensive review on tier 2 safety pharmacology;International Journal of Pharmaceutical Chemistry and Analysis;2023-07-15